| For: | Xiong SX, Huang LJ, Liu HS, Zhang XX, Li M, Cui YB, Shao C, Hu XL. Dapagliflozin exerts anti-apoptotic effects by mitigating macrophage polarization via modulation of the phosphoinositide 3-kinase/protein kinase B signaling pathway. World J Diabetes 2025; 16(2): 97287 [PMID: 39959262 DOI: 10.4239/wjd.v16.i2.97287] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i2/97287.htm |
| Number | Citing Articles |
| 1 |
Liyuan Cao, Lu Ding, Qinjing Xia, Zepeng Zhang, Min Li, Siyu Song, Kai Yin, Zirui Li, Xueyan Li, Zihan Wang, Daqing Zhao, Xiangyan Li, Zeyu Wang. Macrophage polarization in diabetic vascular complications: mechanistic insights and therapeutic targets. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-07075-0
|
| 2 |
Amin Ullah, Bairong Shen. Immunomodulatory effects of anti-diabetic therapies: Cytokine and chemokine modulation by metformin, sodium-glucose cotransporter 2 inhibitors, and glucagon-like peptide-1 receptor agonists (2013–2025). European Journal of Medicinal Chemistry 2025; 299: 118065 doi: 10.1016/j.ejmech.2025.118065
|
| 3 |
Gehad Farouk Abdelhafez, Sylvia A. Boshra, Hagar B. Abo-Zalam, Sara M. Radwan. Dapagliflozin Ameliorates Doxorubicin-Induced Chemobrain and Cognitive Abnormalities in Rats: Modulation of AKT/GSK-3β and Wnt/β-Catenin Pathways. Neurochemical Research 2025; 50(5) doi: 10.1007/s11064-025-04538-0
|
